Presently Dr. Resor is working as a principle investigator for Eisai Pharmaceuticals in an extended assess program for lorcaserin in intractable epilepsies. Thru 2017 he had done consulting and speaker programs for Abbott, GlaxoSmithKline, Eisai Pharmaceuticals, Lundbeck Pharmaceuticals,           Upsher-Smith Laboratories Inc., Sunovion Pharmaceuticals.